Whether simple or complex, the Observational Protocols underlying Circles are the basis for clinically significant evidence. Key to generating this evidence in an efficient manner is asking the right questions, and only the right questions which are specific to a given indication and/or treatment protocol. RegenMed works with physicians to identify those right questions.
inCytes™ and Benchmarc™ enable efficient Case creation, patient enrollment, clinical data entry, outcomes capture, patient education, new Circle Member invitations, roles and permission settings, and report generation. Through business associate agreements, including its own Service Provider Agreement, RegenMed can handle these matters for clients. RegenMed also provides support for co-investigator recruitment and onboarding. These processes allow clinicians to reclaim time for patient care, and office staff to focus on existing responsibilities.
Physicians want to collaborate, especially those treating similar patient populations. RegenMed works with Circle Founders to identify those potential thought-partners, wherever they may be located. It then supports sustained collaboration through Circle Hours, Circle-specific newsletters, Circle Academy, and other efficient, secure channels.
INFLUENCE AND PUBLICATION
RegenMed helps Circle Members ensure that their real-world evidence sees the light of day. We generate reports, propose commentary, suggest screenshots, prepare slides, develop digital front doors and website pages, extend social media presence. We also help make the connection between publication/influence and financial reward.
CIRCLES DATA CONTROL
Circles generate valuable data. RegenMed works with Circle Members to ensure that only the desired individuals or groups have access to specified data. Much of this control is available through inCytes™ roles and permissions settings. We also help Circle Members develop the legal rights to value deriving from Circles datasets.
MONETIZATION OF CIRCLES DATA
RegenMed supports Circle Members as an ethical intermediator with industry and foundations. Relevant sub-processes include investigator-initiated trial proposals, support for IRB approvals, IND and IDE submissions for new indications, royalties for new products and product improvement, and data licensing.
REPORTS AND ANALYTICS
inCytes™ generates multi-variable reports based on the real-world data captured by a single Circle Member, or the aggregated data captured by all (or a subset of) Circle Members. Unlike many data platforms, a Circle Member may easily export all of his raw data at any time. In addition, RegenMed can provide other analytics, such as patient compliance at any outcomes capture point, number of Cases shared among Circle Members, total data points captured, and other.